Skip to content
lifestyle.celebhomes.net
Author:
Abbisko Therapeutics Co., Ltd.
PIMJETMI® (pimicotinib) Developed by Abbisko Therapeutics and Licensed by Merck KGaA, Darmstadt, Germany Receive U.S. FDA Approval for TGCT
November 10, 2026